Enduring Material

Psound Bytes CME: Diagnosis and Treatment of Hard-To-Treat Psoriasis
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Wednesday, July 7, 2021 - Friday, July 7, 2023
30 minutes
National Psoriasis Foundation
Virtual Conference Room
Psound Bytes CME Podcast
National Psoriasis Foundation
Objectives
  • Increased understanding of diagnosing and treating psoriasis affecting the eyes, ears and mouth
Presentations and Speakers
Psound Bytes CME: Diagnosis and Treatment of Hard-To-Treat Psoriasis
  • Robert Kalb, MD
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Diagnosing and treating uncommon areas affected by psoriasis can be challenging. Hear Dr. Robert Kalb, Clinical Professor, Dept of Dermatology at SUNY, Buffalo School of Medicine in Buffalo, NY, address such hard-to-treat areas as the eyes, ears and mouth. This program is supported by educational grants from Lilly, Bristol Myers Squibb, Novartis and Ortho Dermatologics.
Disclosure Statements
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Speakers:
Robert Kalb, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • AbbVie - Contracted Research - Relationship Has Not Ended
  • Amgen - Consulting - Relationship Has Not Ended
  • Amgen, Galderma, Janssen-Ortho, Menlo Therapeutics, UCB - Contracted Research - Relationship Has Not Ended
  • Janssen-Ortho, Menlo Therapeutics, Sun Pharmaceutical, UCB - Consulting - Relationship Has Not Ended

Support for this activity is gratefully acknowledged from BMS. Support for this activity is gratefully acknowledged from Eli Lilly & Company. Support for this activity is gratefully acknowledged from Novartis. Support for this activity is gratefully acknowledged from Ortho.
Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
100 %
7/7/2021
Continue to Enduring Material